Investigational Site Number 840090 — Rock Island, Illinois

Investigational Site Number 840090 is a clinical research site located in Rock Island, Illinois, United States 61201.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840090 has participated in 1 clinical trials.

Therapeutic areas: Atherosclerotic Cardiovascular Disease.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rock Island

Browse all research sites in Illinois · View every site in Rock Island

• Trinity Medical Center
• Virdi Eye Clinic
• Research Site
• Virdi Eye Clinic & Laser Vision Center
• Advanced CardioVascular Consultants
• Virdi Eye Clinic and Laser Vision Center
• ELIOS Vision Clinical Site
• Orasis Investigative Site
• Nicox Clinical Site
• 193
• Site Reference ID/Investigator# 39670
• Investigational Site Number 840021

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840090?

Investigational Site Number 840090 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840090 conducted?

Investigational Site Number 840090 has 1 clinical trials on record. Their work covers Atherosclerotic Cardiovascular Disease.

Is Investigational Site Number 840090 accredited by Crixeo Clinical Trials?

Investigational Site Number 840090 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840090?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.